-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation Program: Oral and Poster Abstracts
Type: Poster
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Laura M Kettyle, BSc1*, Ivan Grishagin, PhD1*, Glenda J Dickson, PhD2*, Charles-Etienne Lebert-Ghali, PhD3*, Janetta Jacoba Bijl, PhD3*, Mary Frances McMullin, MD, FRCPath, FRCP4, Terence R.J. Lappin, PhD, FRCPath5, Ken I Mills, Ph.D., FRCPath1 and Alexander Thompson, PhD1

1Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom
2Rayne Institute/Department of Haemato-Oncology, King's College London, London, United Kingdom
3HMR Research Center, Université de Montréal, Montréal, QC, Canada
4Queen's University Belfast, Belfast, United Kingdom
5Haematology, Queen's University Belfast, Belfast, United Kingdom

Yoko Tabe, MD, PhD1,2, Marina Konopleva, MD, PhD3, Norikazu Monma, PhD4*, Kazuho Ikeo, PhD4*, Kaoru Mogushi, PhD5*, Yasunari Yamanaka, MD, PhD6*, Hiromichi Matsushita, MD, PhD7, Takashi Miida, MD.PhD8*, Yoshihide Hayashizaki, MD, PhD6* and Michael Andreeff, MD, PhD9

1Section of Molecular Hematology & Therapy, Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston
2Department of Clinical Laboratory Medicine, Juntendo Univerisity School of Medicine, Tokyo, Japan
3Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Center for Information Biology, National Institute of Genetics, Sizuoka, Japan
5Center for Genomic and Regenerative Medicine, , Juntendo University Graduate School of Medicine, Tokyo, Japan
6Preventive Medicine & Diagnosis Innovation Program, RIKEN, kanagawa, Japan
7Department of Laboratory Medicine, Tokai University School of Medicine, Kanagawa, Japan
8Department of Clinical Laboratory Medicine, Juntendo University School of Medicine, Tokyo, Japan
9Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX

Hengyou Weng, PhD1,2, Huilin Huang, PhD2, He Huang, PhD3*, Okwang Kwon3*, Ping Chen1, Xi Jiang, PhD1,2, Chao Hu1,2,4*, Hao Huang, PhD1, Yungui Wang, PhD1,2,4*, Xi Qin5*, Stephen Arnovitz1*, Shenglai Li1*, Jennifer Strong2*, Rui Su, PhD2, Mary Beth Neilly1*, Zejuan Li, MD, PhD1, Yingming Zhao3* and Jianjun Chen, PhD1,2

1Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
2Department of Cancer Biology, University of Cincinnati, Cincinnati, OH
3Ben May Department for Cancer Research, University of Chicago, Chicago
4Department of Hematology, The First Affiliated Hospital Zhejiang University, Hangzhou, China
5University of Cincinnati, Cincinnati

Hiroto Ohguchi, MD, PhD1*, Teru Hideshima, MD, PhD1, Manoj Bhasin, PhD2*, Gullu Gorgun, PhD1, Loredana Santo, MD3*, Michele Cea, MD1*, Naoya Mimura, MD, PhD1, Rikio Suzuki, MD, PhD1, Yu-Tzu Tai, PhD4, Ruben D. Carrasco, MD, PhD5, Noopur S. Raje, MD3, Paul G. Richardson, MD1, Hideo Harigae, MD, PhD6, Takaomi Sanda, MD, PhD7 and Kenneth C. Anderson, MD8

1Dana-Farber Cancer Institute, Boston, MA
2BIDMC Genomics, Proteomics, Bioinformatics and Systems Biology Center, Boston, MA
3Massachusetts General Hospital Cancer Center, Boston, MA
4Harvard Medical School, the Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA
5Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
6Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan
7Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
8Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Yawei Zheng1*, Hongyan Zhang1*, Yajie Wang1*, Fang Dong, PhD1*, Sha Hao, Ph.D.1*, Xiaobing Zhang, PhD1,2,3* and Tao Cheng, MD1,3,4

1State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Tianjin, China
2Department of Medicine, Loma Linda University, Loma Linda, CA
3Department of Stem Cell and Regenerative Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
4Center for Stem Cell Medicine, Tianjin, China

Anjali Mishra, Ph.D.1, Sonya Kwiatkowski2*, Laura Sullivan2*, Leah Grinshpun2*, Giandomenico Russo, MD, PhD3, Pierluigi Porcu, MD4,5 and Michael A. Caligiuri, MD6

1The Ohio State University Comprehensive Cancer Center, Columbus, OH
2The Ohio State University Comprehensive Cancer Center, Columbus
3Istituto - Dermopatico Dell 'Immacolata, Rome, Italy
4The Ohio State University Wexner Medical Center, Columbus, OH
5Division of Hematology, The Ohio State University, Columbus, OH
6Comprehensive Cancer Center, The Ohio State University, Columbus, OH

Sarah Lynn Ondrejka, DO1, Elaine S Jaffe, MD2, Shunyou Gong3*, Deepthi Rajagopalan4*, Cassandra Love4* and Sandeep Dave, MD5

1Cleveland Clinic, Cleveland, OH
2Laboratory of Pathology, National Cancer Institute, Bethesda, MD
3Northwestern University, Chicago, IL
4Duke University, Durham, NC
5Duke Cancer Institute, Duke University Medical Center, Durham, NC

Vincenzo Giambra, PhD1*, Sonya H Lam2*, Miriam Belmonte2*, Sam Gusscott3*, Sohrab Salehi2*, Fong Chun Chan4*, Robert Kridel, MD, MPH5, Alireza Lorzadeh6*, Catherine Hoofd, PhD2*, Christian Steidl, MD5, Connie J. Eaves, PhD1, Martin Hirst, PhD6* and Andrew P. Weng, MD, PhD7

1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
2Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada
3Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada
4Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada
5Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
6Dept of Microbiology and Immunology, University of British Columbia, Vancouver, Canada
7Terry Fox Laboratory/Dept of Pathology, BC Cancer Agency, Vancouver, BC, Canada

Xianhuo Wang, M.D.1,2*, Huaqing Wang1*, Chengfeng Bi2*, Xiaoyan Zhang2,3*, Xin Huang2*, Xuan Zhang2*, Javeed Iqbal2*, George W Wright4*, Louis M Staudt5*, Wing C Chan6*, Timothy W McKeithan6*, Ping Wang1*, Huilai Zhang1* and Kai Fu, MD, PhD1,2

1Department of Lymphoma, Sino-US Center for Lymphoma and Leukemia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
2Department of Pathology and Microbiology and Internal Medicine, University of Nebraska Medical Center, Omaha, NE
3Department of Pediatrics, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
4Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD
5Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
6Department of Pathology, City of Hope National Medical Center, Duarte, CA

Tzung-Huei Lai, PhD1, Alma Zecevic2*, Brett Ewald, PhD2*, Liu Chaomei2*, Lara Rizzotto, PhD3, Melanie Sulda2*, Dimitrios Papaioannou, MD4*, Ramiro Garzon, MD5, William Plunkett, PhD2 and Deepa Sampath, PhD6

1The Ohio State University, Columbus, OH
2Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
4Division of Hematology, Comprehensive Cancer center, The Ohio State university, Columbus
5Comprehensive Cancer Center, The Ohio State University, Columbus, OH
6Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH

Ryo Shimizu, MD1*, Tomoya Muto, MD, PhD1*, Masahiro Takeuchi, MD, PhD1, Shuhei Koide2*, Yuhei Nagao, MD1*, Chika Kawajiri, MD1*, Emi Togasaki, MD1*, Nagisa Hasegawa, MD1*, Shio Sakai, M.D., PhD.1,3*, Yusuke Takeda, MD, PhD1*, Naoya Mimura, MD, PhD1,3, Chikako Ohwada, MD, PhD.1, Emiko Sakaida, MD, PhD1*, Tohru Iseki, MD, PhD1,3*, Koutaro Yokote, MD, PhD4*, Atsushi Iwama, MD, PhD2 and Chiaki Nakaseko, MD, PhD1

1Department of Hematology, Chiba University Hospital, Chiba, Japan
2Department of Cellular and Molecular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan
3Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan
4Department of Clinical Cell Biology and Medicine, Graduate School of Medicine, Chiba University, Chhiba, Japan

Maya D. Hughes, MD1,2*, Valerie A. Morris, PhD2*, Carrie Cummings2*, Soheil Meshinchi, MD, PhD2,3,4 and Vivian G. Oehler, MD2,5

1Seattle Children's Hospital, Seattle, WA
2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
3Department of Pediatrics, University of Washington, Seattle
4Children's Oncology Group, Monrovia, CA
5Division of Hematology, University of Washington, Seattle, WA

Eva Gentner, BSc, MSc1,2*, Naidu Vegi, Dr.1*, Medhanie A. Mulaw, Jun. Prof. Dr.1*, Leticia Quintanilla-Fend, Prof. Dr.3*, Hartmut Döhner, Prof. Dr.4, Konstanze Döhner, MD4, Christian Buske1, Vijay P.S. Rawat, Jun. Prof. Dr.1* and Michaela Feuring-Buske, PD Dr.4*

1Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany
2International Graduate School in Molecular Medicine Ulm, Ulm University, Ulm, Germany
3Eberhard Karls University, Institute of Pathology, Tuebingen, Germany
4Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany

Qingxiao Chen, M.Med1*, Jingsong He, PhD1*, Xing Guo, M.Med1*, Jing Chen, M.Med1*, Li Yang, PhD1*, Xuanru Lin, M.Med1*, Yi Li, PhD1*, Enfan Zhang, M.Med1*, Yang Yang, PhD1*, Wenjun Wu, MD1*, Donghua He, PhD1*, He Huang, MD, PhD1, Shizhou Liu, MD, PhD2* and Zhen Cai, MD, PhD1*

1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University, School of Medicine., Hangzhou, China
2Institute of Translational Medicine
 ,Zhejiang University, Hangzhou, China

Shohei Yamamoto, MD, PhD1*, Hui Shi, MD, PhD2,3*, Shi Chen, MD, PhD3*, Peng Zhang, PhD3*, Yuan Zhou, PhD2*, Mingjiang Xu, MD, PhD3 and Feng-Chun Yang, MD, PhD3

1Showa University Fujigaoka Hospital, Yokohama, Japan
2State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Center for Stem Cell Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3Department of Biochemistry and Molecular Biology & Sylvester Comprehensive Cancer Center, University of Miami Leonard M. Miller School of Medicine, Miami, FL

Alessandra Trojani, PhD1*, Ester Pungolino, MD2*, Milena Lodola3*, Barbara Di Camillo4*, Mariella D'Adda, MD5*, Alessandra Perego, MD6*, Mauro Turrini, MD7*, Chiara Elena, MD8*, Alessandra Iurlo, MD, PhD9*, Cristina Buccelli9*, Simona Malato, MD10*, Francesco Spina, MD11*, Maria Luisa Latargia12*, Francesco Lanza13*, Sergio Pauli, MD14*, Michela Anghilieri, MD15*, Maria Cristina Carraro16*, Enrica Morra, MD17 and Roberto Cairoli, MD17*

1Division of Hematology, Niguarda Cà Granda Hospital, Milan, Italy
2Niguarda Cà Granda Hospital, Milan, Italy
3Division of Hematology, Niguarda Hospital, Milano, Italy
4Department of Information Engineering, University of Padova, Padova, Italy
5Division of Hematology, A.O. Spedali Civili of Brescia, Brescia, Italy
6Internal medicine-Haematology, Desio Hospital, Desio, Italy
7Division of Hematology, Valduce Hospital, Como, Italy
8Dept Oncology-Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
9Division of Hematology, IRCCS Maggiore Policlinico Hospital Foundation, Milano, Italy
10Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milano, Italy
11Division of Hematology, IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy
12Ospedale di Circolo, Busto Arsizio, Italy
13Division of Hematology, Hospital of Cremona, Cremona, Italy
14Azienda Ospedaliera Sant'Antonio Abate, Gallarate, Italy
15Manzoni Hospital, Lecco, Italy
16Hematology & Transfusion Medicine, Sacco University Hospital & School of Medicine, Milano, Italy
17Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy

Saara Laukkanen1*, Thomas Liuksiala2*, Matti Nykter2,3*, Merja Heinäniemi4* and Olli Lohi1

1Tampere Center for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland
2Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland
3Department of Signal Processing, Tampere University of Technology, Tampere, Finland
4A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland

Guopan Yu1*, Ling Jiang2*, Changxin Yin1*, Zhixiang Wang1*, Hongsheng Zhou1*, Xuejie Jiang3*, Qifa Liu, MD4 and Fanyi Meng1

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2hematology department, Nanfang Hospital, Guangzhou, China
3Nanfang hospital, Guangzhou, China
4Department of Hematology, NanFang Hospital, Southern Medical University, Guangzhou, China

Marilynn Chow, MS, BS1, Jason D. MacManiman1*, Vincent T. Bicocca, PhD1*, Lina Gao, PhD1*, Joshi A. Alumkal, MD1*, Bill H. Chang, MD, PhD2 and Jeffrey W. Tyner, PhD3

1Oregon Health and Science University, Portland, OR
2Oregon Health & Science University Knight Cancer Institute, Portland, OR
3Knight Cancer Institute, Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, OR

Wayne A. Warner, BS, David Spencer, MD/PhD, Maria Trissal, BS*, Nichole Helton, BS*, Timothy J. Ley, MD and Daniel C. Link, MD

Division of Oncology, Department of Internal Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO

*signifies non-member of ASH